Prescribing practices in hospice patients with adult failure to thrive or debility
Authors:
- 26 November 2013
- journal article
- research article
- Published by Taylor & Francis in Progress in Palliative Care
- Vol. 22 (2) , 69-74
Abstract
Objectives Despite being a common admitting diagnosis, there is very little published literature on medication management in hospice patients admitted with a diagnosis of failure to thrive or debility. The purpose of this study was to describe medication prescribing practices in hospice patients with either of these primary diagnoses by characterizing prescribed medications by name and by pharmaceutical class, and determining whether the patient or the hospice organization provided each medication. Methods A retrospective review of a patient information database compiled by a national hospice organization was conducted. Patients were included in this retrospective study if they were admitted to hospice care with a primary diagnosis of failure to thrive or debility, and if they were admitted on or after 1 January 2010, and discharged by death on or before 31 December 2010. Results Overall 293 patients and 6181 medication entries were evaluated. The most commonly prescribed drugs were acetaminophen, lorazepam, morphine, atropine, prochlorperazine, haloperidol, docusate, aspirin, and bisacodyl. The most commonly prescribed pharmacological classes were opioid and non-opioid analgesics, anxiolytics, anticholinergics, antihypertensives, laxatives, antidepressants, and supplements. The hospice organization provided over 90% of prescriptions for analgesics, antipsychotics, anticholinergics, and anxiolytics, and these medications were discontinued before death in less than 5% of patients. Conclusion Recognized clinical components of failure to thrive syndrome include cognitive impairment, malnutrition, and depression. The hospice organization provided 80% of antidepressants, but infrequently provided appetite stimulants and drugs treating dementia. The most commonly provided drugs were those used for symptoms associated with most end-stage diseases.Keywords
This publication has 16 references indexed in Scilit:
- Providing optimal care to dying patients with dementia.2011
- Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adultsThe American Journal of Geriatric Pharmacotherapy, 2009
- Integrating Palliative Medicine into the Care of Persons with Advanced Dementia: Identifying Appropriate Medication UseJournal of the American Geriatrics Society, 2008
- Medicare and Medicaid programs: hospice conditions of participation. Final rule.2008
- Patient characteristics of women and men cared for during the first 10 years at an inpatient hospice ward in SwedenScandinavian Journal of Caring Sciences, 2006
- An approach to the management of unintentional weight loss in elderly peopleCanadian Medical Association Journal, 2005
- Geriatric failure to thrive.2004
- Hospice Usage by Minorities in the Last Year of Life: Results from the National Mortality Followback SurveyJournal of the American Geriatrics Society, 2003
- Clinical Evaluation of Failure to Thrive in Older PeopleClinics in Geriatric Medicine, 1997
- “Failure To Thrive” in Older AdultsAnnals of Internal Medicine, 1996